These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3683718)

  • 41. Migraine treatment.
    Becker WJ; Gawel M; Mackie G; South V; Christie SN
    Can J Neurol Sci; 2007 Nov; 34(4):S10-9. PubMed ID: 18062466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polytherapy for migraine prophylaxis.
    Casucci G; Villani V; Cologno D; D'Onofrio F
    Neurol Sci; 2012 May; 33 Suppl 1():S147-50. PubMed ID: 22644191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
    Le Jeunne C; Gómez JP; Pradalier A; Titus i Albareda F; Joffroy A; Liaño H; Henry P; Lainez JM; Geraud G
    Eur Neurol; 1999 Jan; 41(1):37-43. PubMed ID: 9885327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
    Stöckli HR; Sword A
    Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks.
    Andersson PG; Hinge HH; Johansen O; Andersen CU; Lademann A; Gøtzsche PC
    Cephalalgia; 1989 Mar; 9(1):29-32. PubMed ID: 2650879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G; Compagnon A; Rossi A;
    Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug treatment of migraine: Part I. Acute therapy and drug-rebound headache.
    Moore KL; Noble SL
    Am Fam Physician; 1997 Nov; 56(8):2039-48, 2051-4. PubMed ID: 9390098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Methodology of clinical trials in migraine: a rating system].
    Tzourio C; Massiou H; Bousser MG
    Pathol Biol (Paris); 1992 Apr; 40(4):361-6. PubMed ID: 1495821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Controlled therapeutic trials in migraine: methodology and results].
    Baron JC; Bousser MG
    Rev Neurol (Paris); 1982; 138(4):279-95. PubMed ID: 6753081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine.
    Sørensen PS; Hansen K; Olesen J
    Cephalalgia; 1986 Mar; 6(1):7-14. PubMed ID: 3516409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute Migraine Treatment in Adults.
    Becker WJ
    Headache; 2015 Jun; 55(6):778-93. PubMed ID: 25877672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do over-the-counter medications help the physician manage migraine headache?
    Freitag FG
    Curr Pain Headache Rep; 2002 Apr; 6(2):156-61. PubMed ID: 11872188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical trials in migraine: parallel versus crossover studies.
    Kunkel RS
    Neuroepidemiology; 1987; 6(4):209-13. PubMed ID: 3683715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Some comments on the use of statistics in the evaluation of drug trials in migraine.
    Amery WK; Hoing M; Debroye M; Dom F
    Neuroepidemiology; 1987; 6(4):220-7. PubMed ID: 3683717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-centre versus single-centre trials in migraine.
    Hedman C; Andersen AR; Olesen J
    Neuroepidemiology; 1987; 6(4):190-7. PubMed ID: 3683713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Migraine trials: crossover or parallel group?
    Lewis JA
    Neuroepidemiology; 1987; 6(4):198-208. PubMed ID: 3683714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endpoints to evaluate efficacy of symptomatic drugs in migraine: what do patients want?
    Pietrini U; De Luca M; Del Bene E
    Headache; 2002 Oct; 42(9):948-9. PubMed ID: 12390628
    [No Abstract]   [Full Text] [Related]  

  • 59. Phenothiazines in migraine treatment.
    Bigal ME
    Curr Pain Headache Rep; 2010 Aug; 14(4):253-5. PubMed ID: 20490743
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug trials in migraine. The clinician's view on end points.
    Bousser MG; Baron JC
    Neuroepidemiology; 1987; 6(4):228-33. PubMed ID: 3683718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.